Redeye
Coronavirus vaccine must be priced to benefit everyone
Canada has committed millions to research and development of some of the world's most promising candidate vaccines and therapeutics to treat Covid-19. However there is no guarantee that this expenditure of public money will result in a vaccine or treatment that is affordable. Jason Nickerson is the Humanitarian Affairs Advisor for Doctors Without Borders in Ottawa. He argues that public investment should not result in high profits for private corporations.
- Broadcast on:
- 13 Jul 2020
Canada has committed millions to research and development of some of the world’s most promising candidate vaccines and therapeutics to treat Covid-19. However there is no guarantee that this expenditure of public money will result in a vaccine or treatment that is affordable. Jason Nickerson is the Humanitarian Affairs Advisor for Doctors Without Borders in Ottawa. He argues that public investment should not result in high profits for private corporations.
Canada has committed millions to research and development of some of the world's most promising candidate vaccines and therapeutics to treat Covid-19. However there is no guarantee that this expenditure of public money will result in a vaccine or treatment that is affordable. Jason Nickerson is the Humanitarian Affairs Advisor for Doctors Without Borders in Ottawa. He argues that public investment should not result in high profits for private corporations.